D
uring the past 5 years percutaneous balloon valvuloplasty has become the treatment of choice for valvar pulmonary stenosis. l -6 Balloon angioplasty, however, still remains an experimental procedure for unoperated left-sided obstructive lesions.'q8 Lababidi et a18,9 recently reported that percutaneous balloon dilation could be used to successfully treat valvar aortic stenosis. Others have also reported that valvuloplasty can successfully treat valvar aortic stenosis in both childrenr0-15 and adults.r6-l9 However, the total reported experience with balloon angioplasty to treat valvar aortic stenosis in the pediatric population is thus far only 58 patients. In an attempt to evaluate the efficacy and safety of balloon valvuloplasty to treat children with valvar aortic stenosis in a large population, the results of Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry were reviewed.
METHODS
Patient population: Balloon aortic valvuloplasty was performed in 204 children (10.1 f 0.84 years of age) and the results were reported to the VACA Registry from January 1982 through December 1986. The age distribution of the patients is shown in Figure 1 . All members of the VACA Registry were asked to complete a questionnaire on all patients in whom they performed balloon aortic valvuloplasty. The questionnaire contained the following information: date of birth, date of procedure, left ventricular and aortic pressures and cardiac output indexes before and immediately after valvuloplasty, aortic anulus dimension, valvuloplasty balloon dimension, inflation pressure and any complications associated with the procedure. The data from the VACA Registry were then analyzed and form the basis of this report.
No attempt was made by the registry to standardize valvuloplasty indications, the methods used to perform valvuloplasty or to obtain any follow-up information after valvuloplasty. A single valvuloplasty balloon (ranging in diameter from 4 to 25 mm) was used in 163 subjects and 2 balloons side by side (ranging in diameter from 5 to 18 mm) were used in 23 subjects. Neither the balloon size nor number used were specified in 18 subjects.
Statistical analysts: The data are presented as mean f standard deviation. Comparisons were made using either a 2-tailed t test for paired observations, analysis of variance or chi-square testing. Linear regression analysis was used to determine if a relation existed between the ratio of balloon size/anulus size or patient age and the decrease in left ventricular pressure or outflow tract gradient. A p value <0.05 was required as evidence of significance.
RESULTS
Hemodynamic data: Table I lists hemodynamic data before and immediately after valvuloplasty from all 204 subjects who had aortic balloon valvuloplasty attempted. The peak systolic ejection gradient significantly decreased from 77 f 28 to 30 f 14 mm Hg (p <O.OOl) (Figure 2 ). The decrease in peak systolic ejection gradient was due to the combination of a significant decrease in left ventricular systolic pressure (p <O.OOl) and a significant increase in aortic systolic pressure (p <O.OOl) ( Table I) . No significant changes in cardiac index, aortic diastolic pressure or left ventricular enddiastolic pressure were observed after valvuloplasty. No relation was observed between the change in left ventricular systolic pressure or the change in left ventricular outflow tract gradient and age for the group considered as a whole (age vs change in gradient r = 1.23; age vs change in left ventricular pressure r = -0.08), or for infants (<l year of age) versus older children ( Figure  3) . However, the results were poorer in those neonates in whom angioplasty was performed in the first week of life compared to the group as a whole (p <O.OOl) or compared to infants between the ages of 8 days and 1 year (p <O.OOl). In addition, neither the valvuloplasty balloon size, the ratio of balloon/anulus diameters nor the use of 1 or 2 valvuloplasty balloons correlated with the degree of reduction in left ventricular systolic pressure or outflow tract gradient.
Operative aortic valvotomy was subsequently required in 4% (8 of 204) of the children. Balloon valvuloplasty could not be performed in 4 of these patients because it was not possible to cross the aortic valve in a retrograde fashion. Serious complications occurred before performing the valvuloplasty in 2 children (left ventricular perforation and valvuloplasty catheter malfunc- Major life-threatening complications occurred in 11 of 204 subjects (5%) ( Table II) . Five of the 11 children, all <l year of age, died either during the procedure (4 of 5) or within 2 days of the valvuloplasty procedure (1 of 5). There were several specific causes of death in each of these 5. A 7-mm balloon catheter could not be advanced from the right femoral artery into the abdominal aorta in the first infant. On withdrawal of the catheter the iliac/femoral artery was torn and the child exanguinated. Valvuloplasty was not performed. A second infant had undergone a surgical valvotomy at 6 days of age. Due to persistent congestive A fourth infant had a combination of severe valvar aortic stenosis and a mild supravalvar stenosis. The infant died from tamponade shortly after the procedure. The ascending aorta was found to be very hypoplastic and a tear in the aortic root at the supravalvar ridge was noted at autopsy. The fifth infant (previously mentioned) died 2 days after an unsuccessful balloon valvuloplasty and subsequent surgical valvotomy. At necropsy, the infant was noted to have a transverse, circumferential tear in the aorta at the origin of the left common carotid artery.
Other major complications included life-threatening arrhythmias in 3 patients, and in 1 child each perforation of the left ventricle, requiring emergency pericardiocentesis and surgery; dislodgement of the balloon portion of the valvuloplasty catheter in the ascending aorta over a guidewire in the left ventricle requiring emergency surgery to remove the balloon; and perforation of the mitral valve (while performing balloon aortic valvuloplasty using an anterograde approach across the atria1 septum) requiring surgical repair of the mitral valve. Major complications were significantly related to age at valvuloplasty. Nine of 38 children <l year of age developed a major complication whereas only 2 of 166 over 1 year of age had complications, yielding a relative risk of 25.5 for major complications in infancy (chisquare = 28.2; p <O.OOl). Angioplasty performed during the first month of life is associated with the highest rate of complications (Figure 4) .
Aortic regurgitation developed or increased in severity in 21 of 204 children. The aortic regurgitation increased by I1 degree in 14 of the children, while the increase in regurgitation was moderate in 3 children and severe in 4. No difference in the incidence of aortic insufficiency existed between those patients under the age of 1 year (6 of 38) and those over the age of 1 year at the time of valvuloplasty (15 of 160). A significant relation was noted between the development of and severity of aortic insufficiency and the ratio of valvuloplasty balloon size/aortic anulus size ( Figure 5) .
Finally, significant bleeding requiring transfusion occurred in 5 of 204, while arterial thrombosis or damage was associated with the valvuloplasty procedure in 25 of 204 (12%). Permanent loss of the femoral artery pulse occurred in 5 of 25 (20%) children. Three resulted from femoral arteries that could not be repaired. No explanation for the failure of femoral pulse to return to normal was given in 2 others. In the other 20 of 25 children the femoral pulse returned to normal after treatment with heparin in 4, streptokinase or urokinase in 7, or after surgical thrombectomy in 6. A significant association between age and femoral thrombosis was observed. Loss of femoral pulse occurred in 12 of 38 children under the age of 1 while only 13 of 160 children over the age of 1 lost the femoral pulse (relative risk = 5.2, chi-square = 86, p = 0.005). In an attempt to evaluate the relation between valvuloplasty balloon size (independent of age) and the incidence of femoral artery thrombosis, we compared the ratio of balloon size/anulus between those children who did and did not develop arterial thrombosis. The ratio of balloon size/anulus size was significantly larger in those children who developed arterial thrombosis (0.99 f 0.7 vs 0.91 f 0.03, p = 0.023).
DISCUSSION
Hemodynamic results~ The management of infants and children with moderate to severe aortic stenosis can be challenging. When indicated, surgical aortic valvotomy is an effective means of reducing the aortic stenosis gradient with a low mortality of 1 to 2% in children over the age of 1 year. 2om24 Surgical valvotomy must be considered palliative therapy, however, since aortic regurgitation may occur and restenosis is common.25-29 The present study suggests that percutaneous balloon valvuloplasty may provide an effective alternative to surgical palliation of valvar aortic stenosis in infants and children (> 1 week of age). Balloon valvuloplasty of the aortic valve decreased the peak systolic ejection gradient across the aortic valve in 192 of 204 infants and children to levels comparable to those achieved by surgical valvotomy. For children >l year of age aortic stenosis gradients after valvuloplasty averaged 30 f 6 mm Hg and for children <l year of age the gradients averaged 27 f 51 mm Hg (Figure 3) The mechanism by which balloon valvuloplasty reduces the gradient in congenital valvar aortic stenosis has not been clearly defined, but evidence suggests that tears are produced along lines of commissural fusion. McKay et a130 performed necropsy or intraoperative balloon dilation in 3 patients with aortic stenosis and commissural fusion (1 with congenital bicuspid and 2 with postrheumatic aortic stenosis). In each instance, balloon dilation resulted in separation of the fused commissures along the commissural lines. Lababidi et ala9 reported intraoperative observations of the aortic valve in 2 children who underwent elective surgical valvotomy after unsuccessful percutaneous balloon valvuloplasty. Each bicuspid aortic valve was found to have a 2-to 4-mm tear along the free edge of the fused commissure. The anatomic changes after more successful balloon aortic valvuloplasty in childhood have not been reported.
Complications:
In addition to documenting the acute efficacy of balloon aortic valvuloplasty for the treatment of valvar aortic stenosis, this study also documents a number of complications directly associated with the procedure, including death, aortic regurgitation, femoral artery thrombosis or damage, excessive blood loss, life-threatening arrhythmias and damage to other cardiac structures. Four deaths were directly related to the valvuloplasty procedure, and all 4 occurred in infants under the age of 3 months. However, critical aortic stenosis carries a grave prognosis even if treated surgical1y.31-36 In a recent report by Pelech et al, 31 survival for neonates undergoing surgical therapy for critical aortic stenosis was only 43%. Even though the registry data do not specify why the 38 infants underwent balloon aortic valvuloplasty as opposed to surgical therapy, the survival rate of 87% for the valvuloplasty group is remarkable. When the causes of death in these infants were reviewed, we found that 1 of these deaths (no. 1, 1 Table II ) may have been prevented if balloons on smaller catheter shafts had been available. Aortic regurgitation occurred in 10% of the children, a figure less than that reported by others.8~'0*'1 Mild to moderate aortic regurgitation has been reported in 10 to 28% of patients after surgical valvotomy.26,27 Although the mechanism by which balloon valvuloplasty produces aortic regurgitation has not been clearly defined, perforation of an aortic valve leaflet and avulsion of cusp tissue from the anulus were observed in 2 of the infants who died (nos. 2 and 3, Table II the presence and severity of aortic regurgitation; the incidence of aortic regurgitation might be reduced by using smaller balloons. Femoral artery thrombosis, damage or both occurred in 12% of the children, and was most common in children under 1 year of age. Femoral artery patency was restored either with medical (heparin, streptokinase or urokinase) or surgical therapy in the majority of instances (80% of the time). Since the development of femoral artery damage was significantly related to both patient age and balloon/anulus ratio, the incidence of this complication may be significantly reduced by the development of new catheters with a smaller shaft size and a lower balloon profile.
Study limitations:
Two major limitations exist. First, since the VACA Registry only collected data on the acute response to aortic balloon valvuloplasty, we have no information to document the long-term efficacy of this procedure. However, based on the reported experience of others,8-11J4 all of whose patients are included in this report, one can postulate that gradient reduction is likely for at least 1 year. To document the true longterm efficacy of aortic balloon valvuloplasty a multicenter long-term follow-up study, including repeat catheterization, will be necessary. The second limitation is that no attempt was made by the registry to standardize the methods used to perform the valvuloplasty; thus, only limited conclusions can be made concerning the technical aspects of the valvuloplasty procedure. In children in whom a single valvuloplasty balloon was used (balloon/anulus ratio of 0.56 to 1.5), no relation was noted between balloon/ anulus ratio and aortic stenosis gradient reduction. Since the complications of aortic regurgitation and femoral artery injury appear to relate to balloon/anulus ratio and since Helgason et al" have shown that a balloon/anulus ratio of >1.2 produced damage to aortic valve leaflets, mitral valve leaflets and intraventricular septum in normal lambs, a balloon/anulus ratio of II should be used.
Clinical implications:
These data suggest that percutaneous balloon valvuloplasty provides effective acute relief of valvar aortic stenosis in both infants (>l week of age) and children. Significant complications of the valvuloplasty procedure included death, aortic regurgi-tation and femoral artery thrombosis or damage. These complications, however, appeared to be uncommon if valvuloplasty was performed on children older than 1 month of age, and if the balloon/anulus size ratio was 5 1 .O. Long-term follow-up data should be collected before percutaneous balloon valvuloplasty can be established as treatment of choice for children with valvar aortic stenosis.
